| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |